Brief: Endo To Cease Production And Sale Of Qwo® (Collagenase Clostridium Histolyticum-Aaes)

Endo International

06/12/2022 22:10

Dec 6 (Reuters) - Endo International PLC  ENDPQ.PK :
    * ENDO TO CEASE PRODUCTION AND SALE OF QWO® (COLLAGENASE
CLOSTRIDIUM HISTOLYTICUM-AAES)
    * ENDO INTERNATIONAL PLC - THIS DECISION IS EXPECTED TO
RESULT IN
ANNUALIZED PRE-TAX CASH SAVINGS OF APPROXIMATELY $50 MILLION TO
$60 MILLION
    * ENDO INTERNATIONAL PLC - THIS DECISION IS EXPECTED TO
RESULT IN
REDUCTION TO ENDO'S GLOBAL WORKFORCE OF APPROXIMATELY 90
FULL-TIME POSITIONS
    * ENDO INTERNATIONAL PLC - COMPANY EXPECTS TO INCUR PRE-TAX
CASH
RESTRUCTURING CHARGES OF APPROXIMATELY $15 MILLION TO $20
MILLION
    * ENDO INTERNATIONAL PLC - CO EXPECTS TO RECORD A TOTAL
PRE-TAX
RESTRUCTURING CHARGE OF APPROXIMATELY $235 MILLION TO $250
MILLION IN Q4 2022
    * ENDO INTERNATIONAL - CO WILL SEEK ANY NECESSARY APPROVALS
FROM
U.S. BANKRUPTCY COURT FOR SOUTHERN DISTRICT OF NEW YORK IN
CONNECTION WITH THE DECISION

Source text for Eikon:  ID:nPn58rbZza 
Further company coverage:  ENDPQ.PK 
 ((Reuters.Briefs@thomsonreuters.com;;))